Accumulating evidence has indicated that NUF2 expression is upregulated in a series of human cancers, including colorectal 14, stomach 14, oral cancers 24, breast cancer 25, and osteosarcoma 26, and that the depletion of NUF2 suppresses cancer cell growth. Here, NUF2 is linked to osteosarcoma.